Company: BLND
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001855747-25-000041
Chunk: 490

Company: Blend Labs, Inc.
Filing Date: 2025-05-08
Form: 10-Q
Item: Part I, Item 1
Chunk 490
---
876)(48,312)Sale of available-for-sale securities848100,297Maturities of marketable securities18,92710,600Additions to property, equipment and internal-use software development costs(4,587)(1,964)Net cash provided by investing activities - continuing operations3,31260,621Net cash used in investing activities - discontinued operations(84)—Net cash provided by investing activities3,22860,621Financing activitiesProceeds from exercises of stock options, including early exercises, net of repurchases363619Taxes paid related to net share settlement of equity awards(2,971)(3,806)Share repurchases(2,568)—Net cash used in financing activities - continuing operations(5,176)(3,187)Effect of exchange rates on cash, cash equivalents, and restricted cash—(4)Net increase in cash, cash equivalents, and restricted cash18,44253,562Cash, cash equivalents, and restricted cash at beginning of period49,53738,253Cash, cash equivalents, and restricted cash at end of period67,97991,815Less: Cash, cash equivalents and restricted cash included in current assets held for sale from discontinued operations6,7129,213Cash, cash equivalents and restricted cash, end of period, excluding current assets held for sale from discontinued operations$61,267$82,602Reconciliation of cash, cash equivalents, and restricted cash within the condensed consolidated balance sheets:Cash and cash equivalents$56,244$77,579Restricted cash5,0235,023Total cash, cash equivalents, and restricted cash$61,267$82,602Supplemental disclosure of cash flow information:Cash paid for income taxes$133$9Cash paid for interest$—$4,529Supplemental disclosure of non-cash investing and financing activities:Reclassification of redeemable noncontrolling interest related to discontinued operations to equity$52,675$—Vesting of early exercised stock options$—$184Operating lease liabilities arising from obtaining new or modified right-of-use assets$—$654Stock-based compensation included in capitalized internal-use software development costs$1,218$636Accretion of redeemable noncontrolling interest related to discontinued operations to redemption value$1,254$1,461Accretion of Series A redeemable convertible preferred stock to redemption value$4,202$—Capitalized internal-use software development costs included in accrued compensation$528$201

See accompanying notes to condensed consolidated financial statements